EcoDrugPlus

Mitogen-Activated Protein Kinase Kinase Kinase 5

Ensembl ID : ENSPEMG00000015212
Gene Symbol: MAP3K5
1 Cross references
203 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase Kinase 8

Ensembl ID : ENSPEMG00000020056
Gene Symbol: MAP3K8
3 Cross references
198 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase Kinase 9

Ensembl ID : ENSPEMG00000018982
Gene Symbol: MAP3K9
3 Cross references
194 Possible Orthologues:

Monoamine Oxidase A

Ensembl ID : ENSPEMG00000006637
Gene Symbol: MAOA
1 Cross references
147 Possible Orthologues:

Monoamine Oxidase B

Ensembl ID : ENSPEMG00000000761
Gene Symbol: MAOB
3 Cross references
328 Possible Orthologues:

Monoglyceride Lipase

Ensembl ID : ENSPEMG00000009625
Gene Symbol: MGLL
1 Cross references
208 Possible Orthologues:

Myeloperoxidase

Ensembl ID : ENSPEMG00000014344
Gene Symbol: MPO
2 Cross references
180 Possible Orthologues:

Myeloperoxidase-Like

Ensembl ID : ENSPEMG00000015337
Gene Symbol: LOC102927518
2 Cross references
180 Possible Orthologues:

Myeloproliferative Leukemia Virus Oncogene

Ensembl ID : ENSPEMG00000014630
Gene Symbol: MPL
1 Cross references
186 Possible Orthologues:

Natriuretic Peptide Receptor 1

Ensembl ID : ENSPEMG00000018127
Gene Symbol: NPR1
3 Cross references
184 Possible Orthologues:

Natriuretic Peptide Receptor 2

Ensembl ID : ENSPEMG00000008535
Gene Symbol: NPR2
3 Cross references
259 Possible Orthologues:

Natriuretic Peptide Receptor 3

Ensembl ID : ENSPEMG00000010364
Gene Symbol: NPR3
3 Cross references
211 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).